UBS on Seattle Genetics - SEAGEN INC COM (NASDAQ:SGEN)

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

In a research note released Wednesday, UBS analyst Matthew Roden Upgraded Seattle Genetics, Inc. (NASDAQ: SGEN) to Buy from Neutral and is maintaining a price target of $48.00. The analyst said that they have made the upgrade based on two primary reasons. The first being the stock's underperformance this year due to increased speculation in regards to the phase-3 data expected. The second reason is the analyst believes that the proprietary pipeline development is not reflected in the stock. The analyst continued to say that fear over AETHERA may be overstated and ultimately believes that upside will be driven by the pipeline.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!